Want to join the conversation?
Healthcare diagnostics company $LH said John Ratliff will succeed Deborah Keller as CEO of Covance Drug Development, effective October 1. Mr. Ratliff will be a member of the company's executive committee and will report to David P. King, chairman and CEO of $LH.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.